Rotavirus Surveillance

To allow countries, primarily in Asia and Africa, to continue rotavirus surveillance activities in anticipation of the introduction of the rotavirus vaccine.
Funding Partners:
  • GlaxoSmithKline Biologicals S.A.
  • Merck
Program Partners:
  • CDC's National Center for Immunization and Respiratory Diseases
Program Location:
  • United States of America